KeywordsHepatitis B virus (HBV); HBV X protein; Hepatocellular Carcinoma (HCC); HBV replication; epigenetic regulation; DNA methylation; DNA methyl transferases (DNMTs); Polycomb Repressive complex 2 (PRC2); Suz12; suppressor of zeste 12 homolog (Drosophila); Znf198; zinc finger; MYM-type 2; LSD1-Co-REST-HDAC1; HCLR; herpes viruses; productive infection; latency; cervical cancer; biomarker; histone methylation; tumor suppressor; herpes simplex virus; chromatin; HCF-1; Setd1A; latency; histone demethylase; cytomegalovirus; latency; reactivation; epigenetics; chromatin; intrinsic immunity; transplantation; Kaposi’s sarcoma-associated herpesvirus; KSHV; KS; viral chromatin; polycomb; EZH2; minichromosome; histone modifications; MLL/Set1; JMJD2A; Brd4; BET protein; HPV; papillomavirus; transcription; chromatin; replication; tethering; partitioning; bromodomain; cytomegalovirus; latency; gene expression; chromatin; adenovirus; chromatin; histones; DNA replication; transcription; bromodomains; HIV; PCAF; PBAF; p300; CBP; TRIM28; BRD2; BRD4; herpesvirus; HDAC; IFI16; acetylation; NF-κB; p53; proteomics; metabolomics; chemoproteomics; HIV; non-coding RNA; chromatin remodeling; latency; reactivation; HSV; herpes; PRC; Polycomb; heterochromatin; latency; reactivation; Herpes simplex virus 1; chromatin; silencing; nucleosome; histone; fluorescence recovery after photobleaching (FRAP)
